0417

Welcome to the April issue. Upfront investigates how the FBI catches pharma thieves and researchers who scour disused mines for potential therapeutic compounds. We feature the 2017 Medicine Maker Power List, celebrating the best and the brightest in drug manufacturing and development. We also Sit Down With Daniel O’Connor, Medical Assessor at the Medicines and Healthcare Products Regulatory Agency (MHRA), UK.

Register to download

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

I want to receive an alert when the next issue is available online

Articles featured in this issue

Business & Regulation Business Practice

Celebrating the Power List

04/20/2017 | Stephanie Vine

Celebrating the great and good of drug development: welcome to The Medicine Maker 2017 Power List

Business & Regulation

Medical Miners

04/20/2017 | Stephanie Vine

Intrepid researchers scour disused mines in search of new biochemistries for drug development.

Business & Regulation Standards & Regulation

Catching Cargo Criminals

04/20/2017 | Stephanie Vine

How does the FBI track down culprits of pharma heists?

Manufacture Analytical Science

Making a Difference to Drug Discovery

04/20/2017 | James Strachan

DMS could make early drug discovery cheaper, faster and more efficient.

Business & Regulation Business Practice

Business-in-Brief

04/20/2017 | James Strachan

Bribery accusations, a new whistleblowing policy, and recalls... What’s new for pharma in business?

Manufacture Standards & Regulation

Sticking to Your Stent

04/20/2017 | James Strachan

New patient adherence tablet app incorporates storytelling and patient data.

Discovery & Development Small Molecules

Bringing API Manufacture into Focus

04/20/2017 | Stephanie Vine

The industry is shifting towards biopharmaceuticals, but there is still demand for synthetic APIs.

Discovery & Development Formulation

Going Granular with Microparticulates

04/21/2017 | Nathan H. Dormer

We must overcome the challenges of microparticulates to improve the patient experience.

Business & Regulation Facilities

Hygiene Conundrum

04/21/2017 | Andrei Blasko, Imad A Haidar Ahmad

Hygiene is essential to pharma, but there are a suprising number of ways it can go wrong.

Business & Regulation Biosimilars

Why Are We Still Waiting for Biosimilars?

04/21/2017 | Robert Wessman

President Trump has the opportunity to get healthcare moving by boosting biogeneric use.

Discovery & Development Biosimilars

The Power List 2017

04/21/2017

We forge ahead to celebrate the fantastic individuals involved in bettering the pharma industry.

Business & Regulation Standards & Regulation

Ace Assessor

04/21/2017

We Sit Down With Daniel O'Connor, Medical Assessor at the MHRA, UK.

Manufacture Analytical Science

Bringing Time Back to Biology

04/21/2017 | Robert Karlsson

Surface plasmon resonance has become a go-to tool for biotherapeutic characterization.

Manufacture Bioprocessing - Upstream & Downstream

Making the Media of the Future – Today

04/21/2017

Biopharma manufacturing continues to advance and the demand for new innovations is constant.

Business & Regulation Business Practice

In Conversation with Lukas Utiger of Patheon at CPhI Worldwide 2016

05/03/2017

Charlotte Barker speaks with Lukas Utiger from Patheon.

Other issues of 2017